Skip to main content

Novartis — Deal History & Benchmarks

Total Deals
25
Across 11 therapeutic areas
Total Deal Value
$50.3B
Cumulative transaction value
Most Active Year
2024
14 deals closed
Primary TA
Cardiovascular
20% of deal activity

Market Analysis

Novartis has been involved in 25 transactions totaling $50.3B across Neurology & CNS, Immunology & Autoimmune, Hematology, Cardiovascular, Infectious Disease, Ophthalmology, Rare Disease, Dermatology, Metabolic & Obesity, Gastroenterology, Oncology. As both a licensor and licensee, they have demonstrated a preference for licensing partnerships.

PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.

or
Unlock Everything — $299/mo Pro

7-day money-back guarantee · Cancel anytime

Customize these benchmarks for your asset

Adjust phase, modality, competitive position, and 10+ other parameters.

Open Calculator

Frequently Asked Questions

How many deals has Novartis done?
Novartis has completed 25 verified transactions tracked in our database, spanning from 2020 to 2025. These deals have a combined value of $50.3B.
PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.

or
Unlock Everything — $299/mo Pro

7-day money-back guarantee · Cancel anytime

Ready to Calculate Your Deal Terms?

Get instant, customized benchmarks based on real market data from 600+ biopharma licensing deals.

Start Calculating